Bone and Joint Infections Flashcards

1
Q

What are the types of bone and joint infections?

A

osteomyelitis, septic arthritis, prosthetic joint infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is osteomyelitis?

A

infection of the bone causing inflammation of the bone marrow and surrounding bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is septic arthritis?

A

inflammatory reaction within the joint tissue and fluid due to a microorganism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is prosthetic joint infection?

A

infection of a prosthetic joint and joint fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What samples and cultures do we need?

A

tissue/fluid!
▪Culture and susceptibility information is critical to guide antimicrobial treatment
▪Blood cultures important to help further increase likelihood of isolating a pathogen
staphylococcus aureus!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What samples and cultures do we need for osteomyelitis?

A

bone sample/biopsy, commonly obtained via surgical intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What samples and cultures do we need for septic arthitis and prosthetic joint infection?

A

joint aspiration with examination of synovial fluid to establish diagnosis and/or surgical intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibiotic therapy is more intense for bone and joint infections

A

▪Antibiotic therapy given for longer durations and higher doses compared to other types of infection
▪Commonly involves intravenous (IV) antibiotic therapy for the entire duration
▪Antibiotic penetration into infected bone and joints is typically low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the standard treatment duration for bone and joint infections?

A

▪Standard treatment duration ranges from 2-8+ weeks depending upon type of infection
▪Osteomyelitis – 4-8 weeks
▪Septic arthritis – 2-4 weeks
▪Prosthetic joint infection – 6-12+ weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patient-centered care is important

A

▪Antibiotic therapy can be more difficult for patients to tolerate due to adverse effects, insurance coverage/cost, and patient adherence
▪Key considerations:
▪Will the patient need long-term IV access for antibiotic therapy?
▪If IV antibiotic therapy is selected, where will the patient receive it?
⎻ Home vs. facility vs. outpatient infusion
▪If oral antibiotic therapy is selected, will the patient adhere to the regimen if it requires
multiple antibiotics and doses per day?
▪Does the patient have insurance coverage/ability to pay for the treatment plan?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Think outside the box

A

▪Many patients experience barriers to appropriate antibiotic therapy due to the intensity of treatment for bone and joint infections
▪Emerging data for novel approaches to treatment
▪Lipoglycopeptides with long half-lives (e.g., dalbavancin, oritavancin)
▪Oral antibiotic therapy for eligible patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is osteomyelitis pathogenesis?

A

▪The anatomy of blood supply to bone connected to infection risk
▪Nutrient arteries enter on metaphyseal side of epiphyseal growth plate
▪Lead to capillaries forming sharp loops in the epiphyseal growth plate
▪Capillaries lead to large sinusoidal veins that exit metaphysis
▪Bottom line: Blood flow slowed significantly (things slow down, bacteria start to grow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 3 ways osteomyelitis can develop?

A

hematogenous spread
continguous spread
vascular insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is hematogenous spread?

A

microbe reaches bone via bloodstream; typically monomicrobial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is contiguous spread?

A

Microbe reaches bone from soft tissue infection or direct inoculation (e.g., puncture wound, trauma,
surgery); Commonly polymicrobial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is vascular insufficiency?

A

⎻ Microbe reaches bone from soft tissue infection
⎻ Risk factors – diabetes mellitus, peripheral vascular disease
⎻ Commonly polymicrobial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the most common pathogens in osteomyelitis?

A

staphylococcus aureus
post-surgical: pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the presentation of osteomyelitis?

A

▪Signs and symptoms of osteomyelitis – depend on site of infection
▪Acute symptoms – fever, localized pain/tenderness/swelling, decreased range of
motion
▪Chronic symptoms – pain, drainage/sinus tract, decreased range of motion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the diagnostic considerations for osteomyelitis?

A

▪Laboratory findings – elevated WBC count, ESR, CRP
▪Radiologic findings
⎻ X-ray – soft tissue swelling, periosteal thickening, bone destruction
⎻ CT or MRI
⎻ Nuclear bone scan
▪Bone aspiration, biopsy, and/or surgical debridement for cultures and pathology

20
Q

What are the approaches to osteomyelitis treatment?

A

surgical intervention
antibiotic therapy

21
Q

Osteomyelitis - antibiotic selection

A

▪May hold antibiotic therapy initially while awaiting biopsy/surgical intervention if patient clinically stable
▪Examples: hemodynamically stable, no neurologic effects, no concern for additional site of severe infection
▪Empiric antibiotic selection dependent upon most likely pathogens and involves high-dose IV options

22
Q

What is the empiric antibiotic selection for osteomyelitis?

A

have a beta-lactam plus an anti-MRSA agent
cefazolin, ceftriaxone, cefepime, piperacillin/tazobactam, ampicillin/sulbactam, meropenem, ciprofloxacin, or levofloxacin PLUS vancomycin, daptomycin, or linezolid
if anaerobic coverage desired, metronidazole should be added

23
Q

What is the treatment duration for osteomyelitis?

A

▪General duration range of 4-8 weeks
▪Specific considerations:
▪Vertebral osteomyelitis due to MRSA = 8 weeks
▪Diabetic foot infection related osteomyelitis
⎻ Complete resection of all infected bone/tissue = 2-5 days (ex. below knee amputation)
⎻ Resection of all osteomyelitis, soft tissue infection remains = 1-2 weeks
⎻ Resection performed, osteomyelitis remains = 3 weeks
⎻ No resection = 6 weeks

24
Q

What are the oral antibiotic therapy options for osteomyelitis?

A

▪Streptococci – amoxicillin, cephalexin, clindamycin (if susceptible)
▪MSSA – dicloxacillin, cephalexin, cefadroxil, TMP/SMX, linezolid
▪MRSA – linezolid, TMP/SMX, clindamycin (if susceptible)
▪GNRs – TMP/SMX, fluoroquinolones
may consider the addition of rifampin with strep, MSSA, MRSA to help prevent biofilm production

25
Q

Why is dalbavancin a novel approach in osteomyelitis?

A

▪Dalbavancin 2-dose strategy
▪Dalbavancin 1500 mg IV on day 1 and 8 – provides 6-8 weeks of coverage because it has a half-life of 346 hours

26
Q

What is the pathogenesis of septic arthritis?

A

▪Septic arthritis develops via 3 main pathways: Hematogenous, Direct inoculation, Contiguous
infection in joint cavity of synovial fluid

27
Q

What are the risk factors for septic arthritis?

A

▪Joint disease
▪Advanced age
▪Chronic disease (e.g., diabetes mellitus) ▪Sexually transmitted infection ▪Immunosuppression
▪Trauma
▪Prosthetic joint
▪IV drug use
▪Endocarditis

28
Q

What are the most common pathogens in septic arthritis?

A

staphylococcus aureus
sexually active adults: neisseria gonorrhoeae

29
Q

What is the presentation of septic arthritis?

A

▪Joint pain, decreased range of motion, swelling,
erythema, warmth, fever, chills
▪Monoarticular in the majority of cases
▪Polyarticular can occur – rheumatoid arthritis, immunosuppression, prolonged bacteremia

30
Q

What are the diagnostic considerations of septic arthritis?

A

▪Laboratory findings – increased WBC count, ESR, CRP
▪Arthrocentesis – purulent, low viscosity synovial fluid
⎻ Polymorphonuclear neutrophil (PMN) count > 50,000 cells/mm3
⎻ Gram stain and culture
▪Radiologic findings – x-ray, CT, MRI

31
Q

What is the approach to treatment for septic arthritis?

A

▪Expedited joint drainage and antibiotic therapy critical to reduce joint destruction and long-term consequences

32
Q

What is the empiric antibiotic therapy for septic arthritis?

A

comparable to that of osteomyelitis
▪If gram stain available prior to antibiotic initiation, acceptable to use narrowest possible agent
⎻ Example: Gram negative diplococci – likely N. gonorrhoeae – ceftriaxone alone

33
Q

What is the treatment duration of septic arthritis?

A

ranges from 2-4 weeks
▪S. aureus, GNR – 4 weeks
▪Streptococci – 2 weeks
▪N. gonorrhoeae – 7-10 days

34
Q

What is the pathogenesis of prosthetic joint infections?

A

▪Prosthetic joint infections develop via same 3 mechanisms as previously discussed (Hematogenous, Direct inoculation, Contiguous)
▪Involves development of biofilm – impedes antibiotic penetration

35
Q

What are the most common pathogens of prosthetic joint infections?

A

staphylococcus aureus

36
Q

What is the presentation of prosthetic joint infections?

A

▪Joint pain (acute or chronic), decreased range of motion, swelling, erythema, warmth,
fever, chills
▪Sinus tract or persistent wound drainage over joint prosthesis
▪Loosening of prosthesis
▪Important to review history of prosthesis (e.g., type of prosthesis, implantation date, history of wound healing)

37
Q

What are diagnostic considerations for prosthetic joint infections?

A

▪Laboratory findings – increased WBC count, ESR, CRP
▪Arthrocentesis – cell count/differential, gram stain, and culture
▪Radiologic findings – x-ray

38
Q

What is the approach to treatment of prosthetic joint infections?

A

surgical intervention and antibiotic therapy

39
Q

What are the primary types of surgical intervention for prosthetic joint infections?

A
  1. Debridement and retention of
    prosthesis (rinse out the joint)
  2. 1-stage exchange (take out infected joint, put new one in infected area)
  3. 2-stage exchange (take infected one out, put a spacer in, wait 6 weeks on IV antibiotics, put in new joint)
40
Q

What is the approach to treatment for prosthetic joint infections?

A

▪Withholding antimicrobial therapy in stable patients appropriate to increase chances of isolating an organism from culture

41
Q

What is the empiric therapy in prosthetic joint infections?

A

comparable to that of osteomyelitis
▪If gram stain available prior to antibiotic initiation, acceptable to use narrowest possible agent

42
Q

What is the pathogen-directed treatment of prosthetic joint infections?

A

▪Proceed with pathogen-directed treatment once culture and susceptibilities are known
▪IV or highly bioavailable oral is acceptable
▪Rifampin added to treatment for retention of prosthesis or 1-stage exchange
preferred oral agents same as for osteomyelitis

43
Q

What is the treatment after debridement and retention of prosthesis?

A

pathogen direct treatment + rifampin x 2-6wks
oral antibiotic treatment + rifampin x 3 mo (hip), 6 mo (knee/other joint)

44
Q

What is the treatment after 1-stage exchange?

A

pathogen-directed treatment + rifampin x 2-6wks
oral antibiotic treatment + rifampin x 3mo

45
Q

What is the treatment after stage-2 exchange?

A

pathogen-directed treatment x 4-6wks

46
Q

What is the treatment after amputation with complete removal of infected bone/hardware?

A

pathogen directed treatment x 24-48hrs